Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Tan

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|February 12, 2026
ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal AntibodiesYufeng Song, Frances Mehl, Tom No, et al.
Nature|April 1, 2021
Structural basis of malaria RIFIN binding by LILRB1-containing antibodiesYiwei Chen, Kai Xu, Luca Piccoli, et al.
Plos Pathogens|December 6, 2021
Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite proteinLawrence T Wang, Lais S Pereira, Patience K Kiyuka, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Nature|August 29, 2017
Public antibodies to malaria antigens generated by two LAIR1 insertion modalitiesKathrin Pieper, Joshua Tan, Luca Piccoli, et al.
The Journal of Experimental Medicine|March 4, 2021
Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria, and produce functional IgMChristine S Hopp, Padmapriya Sekar, Ababacar Diouf, et al.
Science Translational Medicine|June 24, 2021
Functional human IgA targets a conserved site on malaria sporozoitesJoshua Tan, Hyeseon Cho, Tossapol Pholcharee, et al.
Science Translational Medicine|September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concernHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Cell|July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|February 12, 2026
ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal AntibodiesYufeng Song, Frances Mehl, Tom No, et al.
Nature|April 1, 2021
Structural basis of malaria RIFIN binding by LILRB1-containing antibodiesYiwei Chen, Kai Xu, Luca Piccoli, et al.
Plos Pathogens|December 6, 2021
Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite proteinLawrence T Wang, Lais S Pereira, Patience K Kiyuka, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Nature|August 29, 2017
Public antibodies to malaria antigens generated by two LAIR1 insertion modalitiesKathrin Pieper, Joshua Tan, Luca Piccoli, et al.
The Journal of Experimental Medicine|March 4, 2021
Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria, and produce functional IgMChristine S Hopp, Padmapriya Sekar, Ababacar Diouf, et al.
Science Translational Medicine|June 24, 2021
Functional human IgA targets a conserved site on malaria sporozoitesJoshua Tan, Hyeseon Cho, Tossapol Pholcharee, et al.
Science Translational Medicine|September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concernHyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Cell|July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Pageof 5